Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

被引：0

作者：

Reboursiere, Emilie ^{[1
]}

Le Bras, Fabien ^{[2
]}

Morschhauser, Franck ^{[3
]}

Gyan, Emmanuel ^{[4
]}

Clavert, Aline ^{[5
]}

Malak, Sandra ^{[6
]}

Sibon, David ^{[7
]}

Damge, Marion ^{[8
]}

Gardin, Claude ^{[9
]}

Fornecker, Luc-Matthieu ^{[10
]}

Garidi, Reda ^{[11
]}

Tricot, Sabine ^{[12
]}

Houot, Roch ^{[13
]}

Joly, Bertrand ^{[14
]}

Abarah, Wajed ^{[15
]}

Choufi, Bachra ^{[16
]}

Pham, Anne-dominique ^{[1
]}

Chantepie, Sylvain P. ^{[17
]}

Fruchart, Christophe ^{[1
]}

Gac, Anne-Claire ^{[1
]}

Ollivier, Catherine ^{[1
]}

Marin, Emilie ^{[1
]}

Safar, Violaine ^{[18
]}

Parcelier, Anne ^{[19
,20
]}

Maisonneuve, Herve ^{[21
]}

Bachy, Emmanuel ^{[22
]}

Cartron, Guillaume ^{[23
]}

Jaccard, Arnaud ^{[24
]}

Tournilhac, Olivier ^{[25
]}

Rossi, Cedric ^{[26
]}

Perrot, Aurore ^{[27
]}

Martignoles, Jean-Alain ^{[28
]}

Tilly, Herve ^{[29
]}

Damaj, Gandhi ^{[30
]}

机构：

[1] CHU Caen, F-14000 Caen 5, France

[2] APHM, Bobigny, France

[3] Univ Lille 2, Ctr Hosp Univ, Hematol, Lille, France

[4] CHU Tours, UMR CNRS 7292, Serv Hematol & Therapie Cellulaire, Tours, France

[5] CHU Angers, Hematol, Angers, France

[6] CHU Curie, Paris, France

[7] APHP Necker, Paris 15, France

[8] Inst J Paoli I Calmettes, F-13009 Marseille, France

[9] Hop Avicenne, Hematol, F-93009 Bobigny, France

[10] CHU Strasbourg, F-67000 Strasbourg, France

[11] Hosp St Quentin, St Quentin en Yvelines, France

[12] CHU, Valenciennes, France

[13] Stanford Univ, Stanford, CA 94305 USA

[14] Ctr Hosp Sud Francilien, Dept Hematol, Corbeil Essonnes, France

[15] Hosp Meaux, Meaux, France

[16] Hop Boulogne Sur Mer, Boulogne, France

[17] Caen Univ Hosp, Dept Haematol, Caen, France

[18] Hosp Civils Lyon, Dept Hematol, Pierre Benite, France

[19] Ctr Hosp Univ, Hematol, Amiens, France

[20] Chu Amiens, Salouel, France

[21] CH, Dept Hematol & Oncol, La Roche Sur Yon, France

[22] Hosp Lyon, Lyon, France

[23] CHR Univ Tours, Montpellier, France

[24] CHU Limoges, Dept Hematol, Ctr Natl Reference Malad Rares Amylose AL & Autre, Limoges, France

[25] CHU Clermont Ferrand, Clermont Ferrand 1, France

[26] CHU, Dijon, France

[27] CHU, Vandoeuvre Les Nancy, France

[28] St Etienne Univ Hosp, St Etienne, France

[29] Ctr Henri Becquerel, Serv Hematol Clin, F-76038 Rouen, France

[30] CHU Caen, Dept Hematol, F-14000 Caen, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Gemcitabine and Liposomal Doxorubicin (GemDox) for the Treatment of Relapsed and Refractory T-Cell Lymphomas
Braunstein, Zachary
Waller, Allyson
Dotson, Emily
McLaughlin, Eric
Hanel, Walter
Reneau, John C.
Addison, Daniel
Porcu, Pierluigi
Brammer, Jonathan E.
BLOOD, 2023, 142
[22] Bendamustine mitoxantrone rituximab (BMR):: A new effective treatment for refractory or relapsed indolent lymphomas.
Weide, R
Heymanns, J
Pandorf, A
Köppler, H
BLOOD, 2001, 98 (11) : 253B - 253B
[23] A Multicenter Phase2 Trial of Linperlisib in Relapsed or Refractory Peripheral T/NK Cell Lymphomas
Song, Yuqin
Li, Zengjun
Wu, Huijing
Jin, Jie
Zhou, Hui
Zhou, Keshu
Zhang, Liling
Peng, Zhigang
Zhang, Zhiye
Cen, Hong
Jia, Youchao
Shuang, Yuerong
Li, Zhiming
Yang, Haiyan
Zou, Liqun
Li, Zhifeng
Zhang, Zhihui
Li, Junmin
Cao, Junning
Qiu, Lugui
Wu, Shaojie
Gong, Tiejun
Xu, Xiaohong
Wang, Zhen
Zhu, Jun
BLOOD, 2023, 142
[24] Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Cutaneous T-cell lymphomas
Zinzani, Pier Luigi
Bonthapally, Vijayveer
Huebner, Dirk
Lutes, Richard
Chi, Andy
Pileri, Stefano
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 228 - 240
[25] Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study
Arcari, Annalisa
Chiappella, Annalisa
Spina, Michele
Zanlari, Luca
Bernuzzi, Patrizia
Valenti, Vanessa
Tani, Monica
Marasca, Roberto
Cabras, Maria Giuseppina
Zambello, Renato
Santagostino, Alberto
Ilariucci, Fiorella
Carli, Giuseppe
Musto, Pellegrino
Savini, Paolo
Marino, Dario
Ghio, Francesco
Gentile, Massimo
Cox, Maria Christina
Vallisa, Daniele
LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1823 - 1830
[26] Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study
Fujino, Takahiro
Okamoto, Haruya
Nishiyama, Daichi
Hayata, Hiroki
Sasaki, Nana
Kobayashi, Tsutomu
Maekura, Chika
Kuwahara-Ota, Saeko
Takimoto-Shimomura, Tomoko
Shimura, Kazuho
Kawaji-Kanayama, Yuka
Inoue, Yu
Chinen, Shotaro
Isa, Reiko
Tsukamoto, Taku
Mizutani, Shinsuke
Shimura, Yuji
Kaneko, Hiroto
Nakao, Mitsushige
Fuchida, Shinichi
Takahashi, Ryoichi
Uchiyama, Hitoji
Uoshima, Nobuhiko
Kuroda, Junya
Kyoto Clin Hematol Study Grp
LEUKEMIA & LYMPHOMA, 2025,
[27] Panoptic clinical review of the current and future treatment of relapsed/refractory T-cell lymphomas: Peripheral T-cell lymphomas
Zinzani, Pier Luigi
Bonthapally, Vijayveer
Huebner, Dirk
Lutes, Richard
Chi, Andy
Pileri, Stefano
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 99 : 214 - 227
[28] Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis
Hong, Jung Yong
Yoon, Dok Hyun
Yoon, Sang Eun
Kim, Seok Jin
Lee, Ho Sup
Eom, Hyeon-Seok
Lee, Hye Won
Shin, Dong-Yeop
Koh, Youngil
Yoon, Sung-Soo
Jo, Jae-Cheol
Kim, Jin Seok
Kim, Soo-Jeong
Cho, Su-Hee
Lee, Won-Sik
Won, Jong-Ho
Kim, Won Seog
Suh, Cheolwon
SCIENTIFIC REPORTS, 2019, 9 (1)
[29] Pralatrexate in patients with recurrent or refractory peripheral T-cell lymphomas: a multicenter retrospective analysis
Jung Yong Hong
Dok Hyun Yoon
Sang Eun Yoon
Seok Jin Kim
Ho Sup Lee
Hyeon-Seok Eom
Hye Won Lee
Dong-Yeop Shin
Youngil Koh
Sung-Soo Yoon
Jae-Cheol Jo
Jin Seok Kim
Soo-Jeong Kim
Su-Hee Cho
Won-Sik Lee
Jong-Ho Won
Won Seog Kim
Cheolwon Suh
Scientific Reports, 9
[30] Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
Broccoli, Alessandro
Stanzani, Marta
Bandini, Giuseppe
Bonifazi, Francesca
Stefoni, Vittorio
Pellegrini, Cinzia
LEUKEMIA & LYMPHOMA, 2013, 54 (08) : 1791 - 1793

← 1 2 3 4 5 →